Cleared Traditional

K060400 - CARDIOBLATE SURGICAL ABLATION GENERATOR

Also marketed or referenced as:
CARDIOBLATE BP2 SURGICAL ABLATION DEVICE, MODEL 60831 CARDIOBLAT

K060400 is the FDA 510(k) clearance for CARDIOBLATE SURGICAL ABLATION GENERATOR by Medtronic, Inc.. It is a Class 2 General & Plastic Surgery device (product code GEI) cleared through the Traditional 510(k) pathway after a 13-day FDA review.

K060400 · Medtronic, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2006
Decision
13d
Days
Class 2
Risk

K060400 is an FDA 510(k) clearance for the CARDIOBLATE SURGICAL ABLATION GENERATOR, MODEL 68000. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Medtronic, Inc. (Brooklyn Park, US). The FDA issued a Cleared decision on February 28, 2006 after a review of 13 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic, Inc. devices

Submission Details

510(k) Number K060400 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 15, 2006
Decision Date February 28, 2006
Days to Decision 13 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d faster than avg
Panel avg: 115d · This submission: 13d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
SILVIA ANKOVA

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 1118
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K060400.
ARTHROCARE WANDS
K060823 · Arthrocare Corp. · Apr 2006
ERBE VIO ESU, MODEL VIO 300 D
K060484 · Erbe USA, Inc. · Mar 2006
CONCERTO BIPOLAR NEEDLE ELECTRODE
K060419 · Boston Scientific Corp · Mar 2006
BOVIE BUTTON REMOTE HAND SWITCH
K060117 · Aaron Medical Industries · Feb 2006
ERBE BICLAMP OPEN AND LAPAROSCOPIC INSTRUMENTS
K060170 · Erbe USA, Inc. · Feb 2006
ERBE APC INTEGRATED FILTER PROBES
K060183 · Erbe USA, Inc. · Feb 2006

Related FDA 510(k) Regulatory Insights

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.